GO:0006776 vitamin A metabolic process: Retinoid Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006776 vitamin A metabolic process describes the chemical reactions and pathways involving retinol, retinal (retinaldehyde), and retinoic acid, all derivatives of beta-carotene.
• Vitamin A is a fat-soluble vitamin essential for vision, epithelial differentiation, immune function, and embryonic development.
• Disturbed vitamin A metabolism is increasingly linked to metabolic diseases such as non-alcoholic fatty liver disease (NAFLD).
• The transcriptional role of vitamin A and the retinoid axis is critical in brown fat function and energy homeostasis.
• Key enzymes and binding proteins in this process include BCO1, BCO2, LRAT, RPE65, ALDH1A1/2/3, CYP26A1/B1/C1, CRBP1/2, and RBP4.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of vitamin A metabolic genes in health and disease.
Description
Vitamin A metabolic process (GO:0006776) encompasses the chemical reactions and pathways involving retinol, retinal (retinaldehyde), and retinoic acid, all of which are derivatives of beta-carotene. This process is fundamental to human physiology, as vitamin A and its metabolites are required for vision, epithelial integrity, immune competence, and embryonic development. The term is a biological process in the Gene Ontology, and its study bridges nutrition, biochemistry, and molecular cell biology. Researchers investigate GO:0006776 to understand how dietary provitamin A carotenoids are converted to active retinoids, how these metabolites are transported and stored, and how their dysregulation contributes to disease. The process is highly relevant to metabolic disorders, including non-alcoholic fatty liver disease (NAFLD), where disturbed vitamin A metabolism has been documented. Moreover, the transcriptional role of vitamin A and the retinoid axis has been implicated in brown fat function, highlighting its broader impact on energy balance. Understanding GO:0006776 at a mechanistic level is therefore essential for developing targeted interventions and for interpreting genomic and proteomic data in nutrition and disease research.
vitamin A metabolic process At A Glance
| GO ID | GO:0006776 |
|---|---|
| GO term | vitamin A metabolic process |
| Ontology | biological_process |
| Synonym | vitamin A metabolism |
| Definition | The chemical reactions and pathways involving any of the vitamin A compounds, retinol, retinal (retinaldehyde) and retinoic acid, all of which are derivatives of beta-carotene. |
| Major function | Production, interconversion, and utilization of retinol, retinal, and retinoic acid for vision, gene regulation, and cellular differentiation. |
| Key substrates | Beta-carotene, retinol, retinal, retinoic acid |
| Key enzymes | BCO1, BCO2, LRAT, RPE65, ALDH1A1/2/3, CYP26A1/B1/C1 |
| Associated diseases | NAFLD, vitamin A deficiency, metabolic disorders, developmental defects |
What Is GO:0006776?
GO:0006776 vitamin A metabolic process is defined by the Gene Ontology as the chemical reactions and pathways involving any of the vitamin A compounds: retinol, retinal (retinaldehyde), and retinoic acid, all of which are derivatives of beta-carotene. This process includes the enzymatic conversion of beta-carotene to retinal, the reversible oxidation-reduction between retinol and retinal, the irreversible oxidation of retinal to retinoic acid, and the further metabolism of these retinoids. It also encompasses the transport, storage, and transcriptional actions of vitamin A derivatives.
Why Is vitamin A metabolic process Important in Cell Biology?
GO:0006776 vitamin A metabolic process is critically important because vitamin A derivatives are essential for vision, immune function, reproduction, and embryonic development, and their dysregulation is linked to a spectrum of human diseases. The process controls the availability of retinoic acid, a potent transcriptional regulator that influences gene expression programs in development and metabolism. Disturbances in this pathway have been observed in non-alcoholic fatty liver disease, where altered vitamin A metabolism may contribute to disease progression. Furthermore, nutritional interventions targeting vitamin A metabolism are relevant to public health strategies. Understanding this process at the molecular level is therefore vital for both basic biology and clinical translation.
• Vitamin A metabolic process is required for the visual cycle, as retinal is the chromophore of rhodopsin.
• Retinoic acid produced via this process acts as a ligand for nuclear receptors that regulate gene expression during development and differentiation.
• Disturbed vitamin A metabolism is associated with non-alcoholic fatty liver disease (NAFLD).
• The process is essential for epithelial cell differentiation and keratinization, with defects leading to skin and mucosal disorders.
• Vitamin A metabolism influences brown adipose tissue function and energy expenditure through transcriptional mechanisms.
• Nutritional targeting of vitamin A pathways is a strategy to combat deficiency and related morbidity.
• Enzymes such as BCO1 and RPE65 are targets for understanding inherited retinal diseases and metabolic conditions.
• The pathway intersects with lipid metabolism and transport, affecting systemic homeostasis.
What Happens During vitamin A metabolic process?
Dietary intake and conversion of beta-carotene
In simple terms: The body gets vitamin A from foods, either as preformed retinol or as beta-carotene that must be converted.
Vitamin A is obtained from the diet as preformed retinoids (retinol, retinyl esters) or as provitamin A carotenoids such as beta-carotene. Beta-carotene is cleaved centrally by beta-carotene 15,15'-monooxygenase (BCO1) to produce retinal, which can then be reduced to retinol or oxidized to retinoic acid. This conversion is a key entry point into GO:0006776 and is regulated by nutritional status and genetic variation.
Transport and storage of retinol
In simple terms: Retinol is packaged and carried through the body to tissues where it is needed.
Retinol is transported in the bloodstream bound to retinol-binding protein 4 (RBP4) and transthyretin, and is taken up by target tissues via STRA6. Inside cells, retinol can be esterified by LRAT for storage in lipid droplets, or oxidized to retinal and retinoic acid. This transport and storage system maintains systemic vitamin A homeostasis and prevents toxicity.
Oxidation to retinal and retinoic acid
In simple terms: Retinol is converted into retinal and then into retinoic acid, the active form that controls genes.
Retinol is reversibly oxidized to retinal by retinol dehydrogenases, and retinal is irreversibly oxidized to retinoic acid by retinaldehyde dehydrogenases (ALDH1A1, ALDH1A2, ALDH1A3). Retinoic acid is the most potent transcriptional activator among vitamin A derivatives and mediates many of the biological effects of GO:0006776. The balance between retinol, retinal, and retinoic acid is tightly controlled by these enzymes.
Catabolism of retinoic acid
In simple terms: Retinoic acid is broken down by specific enzymes to prevent excessive signaling.
Retinoic acid is catabolized by cytochrome P450 enzymes of the CYP26 family (CYP26A1, CYP26B1, CYP26C1) into more polar metabolites for excretion. This catabolism is essential for limiting retinoic acid action in time and space, and its disruption can lead to developmental abnormalities. The interplay between synthesis and degradation determines local retinoic acid concentrations.
Transcriptional and non-transcriptional actions
In simple terms: Retinoic acid enters the nucleus and switches genes on or off, affecting many cell processes.
Retinoic acid binds to nuclear retinoic acid receptors (RARs) and retinoid X receptors (RXRs), which heterodimerize and regulate target gene transcription. This transcriptional role is central to the biological impact of GO:0006776 in development, metabolism, and immunity. Additionally, retinal participates in the visual cycle by binding to opsin in the retina, a non-transcriptional function.
Key Genes Involved in GO:0006776 vitamin A metabolic process
The following genes encode enzymes, binding proteins, and receptors that are core components of GO:0006776 vitamin A metabolic process.
| Gene | Major Role | Research Relevance |
|---|---|---|
| BCO1 | Cleaves beta-carotene to retinal | Key entry enzyme; genetic variants affect provitamin A conversion |
| BCO2 | Oxidizes carotenoids | Modulates carotenoid levels and oxidative stress |
| LRAT | Esterifies retinol for storage | Regulates retinol storage in liver and other tissues |
| RPE65 | Isomerizes retinyl esters in visual cycle | Mutations cause retinal dystrophy; target for gene therapy |
| ALDH1A1 | Oxidizes retinal to retinoic acid | Major retinoic acid synthesis enzyme in many tissues |
| ALDH1A2 | Oxidizes retinal to retinoic acid | Critical for embryonic development and spermatogenesis |
| ALDH1A3 | Oxidizes retinal to retinoic acid | Important in fetal development and cancer |
| CYP26A1 | Catabolizes retinoic acid | Controls retinoic acid gradients in development |
| CYP26B1 | Catabolizes retinoic acid | Regulates retinoic acid in bone and germ cells |
| CYP26C1 | Catabolizes retinoic acid | Modulates retinoic acid in skin and other tissues |
| CRBP1 | Intracellular retinol binding | Facilitates retinol metabolism and transport |
| CRBP2 | Intracellular retinol binding | Specific to small intestine; aids absorption |
| RBP4 | Transports retinol in blood | Marker of vitamin A status and metabolic disease |
| STRA6 | Cell surface receptor for RBP4-retinol | Mediates cellular retinol uptake |
| RARA | Retinoic acid receptor alpha | Mediates transcriptional effects of retinoic acid |
| RARB | Retinoic acid receptor beta | Tumor suppressor and developmental regulator |
| RARG | Retinoic acid receptor gamma | Involved in skin and skeletal development |
| RXRA | Retinoid X receptor alpha | Heterodimer partner for RARs; integrates signaling |
How Is vitamin A metabolic process Regulated?
GO:0006776 vitamin A metabolic process is regulated at multiple levels, including dietary intake, enzymatic activity, and transcriptional feedback. Retinoic acid levels are controlled by the balance between synthesis (ALDH1A enzymes) and degradation (CYP26 enzymes), which is critical for proper development and tissue homeostasis. Nutritional status influences the expression and activity of key enzymes such as BCO1 and LRAT. Additionally, the transcriptional role of vitamin A and the retinoid axis is integrated with metabolic signals in brown fat, where retinoids modulate gene expression programs related to energy expenditure. Disturbances in this regulation are observed in NAFLD, suggesting that metabolic stress can alter vitamin A homeostasis.
vitamin A metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BCO1 | Vitamin A deficiency, altered carotenoid metabolism | Knockout cell line (e.g., HepG2) to assess beta-carotene conversion |
| RPE65 | Leber congenital amaurosis, retinal dystrophy | Knock-in of patient mutations in retinal pigment epithelium cells |
| ALDH1A2 | Developmental defects, spermatogenesis failure | Knockout mouse or cell model to study retinoic acid synthesis |
| CYP26B1 | Skeletal abnormalities, germ cell defects | Point mutation knock-in to abrogate catalytic activity |
| RBP4 | NAFLD, insulin resistance | Overexpression and knockout in hepatocytes to study retinol transport |
Vitamin A deficiency and related disorders
Vitamin A deficiency remains a major public health issue, leading to night blindness, xerophthalmia, and increased susceptibility to infections. Disruption of GO:0006776 at any step, from dietary intake to retinoic acid synthesis, can contribute to deficiency states. Nutritional interventions targeting vitamin A metabolism are therefore critical.
Non-alcoholic fatty liver disease (NAFLD)
Disturbed vitamin A metabolism has been documented in NAFLD, where alterations in retinol and retinoic acid levels may influence disease progression. The liver is a central organ for vitamin A storage and metabolism, and its dysfunction can impair GO:0006776. This link highlights the importance of vitamin A pathways in metabolic liver disease.
Developmental and metabolic disorders
Retinoic acid, produced through GO:0006776, is a key regulator of embryonic development, and its imbalance can cause congenital defects. The transcriptional role of vitamin A in brown fat function also connects this process to energy metabolism and obesity-related conditions. Understanding these connections may inform therapeutic strategies.
Skin and epithelial disorders
Vitamin A is essential for epithelial differentiation and keratinization, and defects in its metabolism can lead to skin disorders. The process GO:0006776 thus has dermatological relevance, and retinoids are used therapeutically for various skin conditions.
From vitamin A metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of BCO1 affect retinoic acid production? | BCO1 knockout cell line (e.g., Caco-2 or HepG2) |
| How do point mutations in RPE65 alter isomerase activity? | Knock-in of specific missense mutations in RPE65-expressing cells |
| Can overexpression of ALDH1A1 increase retinoic acid signaling? | ALDH1A1 overexpression in cell lines with retinoic acid reporter |
| What is the effect of CYP26B1 catalytic-dead mutation? | Point mutation knock-in (e.g., CYP26B1 H-phe mutant) in relevant cells |
| How does tagged RBP4 behave in secretion assays? | Knock-in of FLAG- or HA-tagged RBP4 in hepatocytes |
| Does CRISPR knockout of CRBP1 alter retinol uptake? | CRBP1 knockout in intestinal or hepatic cell lines |
How to Study the vitamin A metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Gene essentiality or pathway activity | Identify novel regulators of vitamin A metabolism |
| RNA-seq | Transcriptome changes | Assess retinoic acid target gene expression |
| LC-MS/MS metabolomics | Retinoid metabolite levels | Quantify retinol, retinal, retinoic acid in cells |
| Western blot | Protein expression | Measure ALDH1A, CYP26, CRBP levels |
| RARE-luciferase reporter | Retinoic acid signaling activity | Screen for modulators of GO:0006776 |
| Immunofluorescence | Protein localization | Visualize RBP4 or CRBP1 trafficking |
| CRISPR knock-in of tags | Endogenous protein dynamics | Study RPE65 or LRAT function in situ |
| Proteomics | Global protein abundance | Profile enzymes in vitamin A pathway |
CRISPR screening for vitamin A metabolic genes
Genome-wide CRISPR knockout or activation screens can identify genes that modulate retinoic acid signaling or vitamin A metabolism. Such screens are powerful for discovering novel regulators of GO:0006776 in an unbiased manner.
RNA-seq and transcriptomics
RNA sequencing can reveal transcriptional changes in response to altered vitamin A metabolism, including retinoic acid target genes. This method helps map the downstream effects of GO:0006776 in various cell types.
Proteomics and metabolomics
Mass spectrometry-based proteomics and metabolomics can quantify enzymes and retinoid metabolites involved in GO:0006776. These approaches provide a systems-level view of pathway activity.
Reporter assays and imaging
Retinoic acid response element (RARE) reporter assays and fluorescence imaging can measure retinoid signaling in live cells. Imaging of fluorescently tagged proteins (e.g., RBP4, CRBP1) allows tracking of vitamin A transport.
How CRISPR Can Be Used to Study GO:0006776 vitamin A metabolic process
Knockout
CRISPR knockout of genes such as BCO1, ALDH1A2, or CYP26B1 can abolish specific steps in GO:0006776, allowing researchers to determine their contribution to retinoic acid production and downstream phenotypes. Knockout cell models are ideal for loss-of-function studies in vitamin A metabolism.
Point Mutation
Introducing precise point mutations (e.g., catalytic-dead versions of ALDH1A2 or RPE65) via CRISPR base editing or homology-directed repair enables dissection of enzymatic activity versus scaffolding functions. Such models are valuable for mimicking human disease variants.
Knock-in
Knock-in of reporter tags (e.g., GFP, FLAG) or disease-associated alleles into endogenous loci (e.g., RBP4, RPE65) allows real-time tracking and functional analysis under physiological expression levels. This approach is particularly useful for studying vitamin A transport and storage.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can elevate levels of enzymes like ALDH1A1 or LRAT to boost retinoic acid synthesis or storage, enabling gain-of-function studies in GO:0006776. Overexpression models help test sufficiency of specific genes in driving vitamin A metabolic phenotypes.
How EDITGENE Supports vitamin A metabolic process Research
Researchers studying vitamin A metabolic process-related genes often need to determine whether a candidate gene is causally involved in retinol, retinal, or retinoic acid biology. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for vitamin A metabolic process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| RPE65 Knockout HEK293 Cell Line | EDJ-KQ2185 | Human | 6121 | Details Get a Quote |
| RBP1 Knockout HEK293 Cell Line | EDJ-KQ4896 | Human | 5947 | Details Get a Quote |
| RBP2 Knockout HEK293 Cell Line | EDJ-KQ5643 | Human | 5948 | Details Get a Quote |
| RLBP1 Knockout HEK293 Cell Line | EDJ-KQ5673 | Human | 6017 | Details Get a Quote |
| ALDH1A2 Knockout HEK293 Cell Line | EDJ-KQ6383 | Human | 8854 | Details Get a Quote |
| RBP1 Knockout A-549 Cell Line | EDJ-KQ28978 | Human | 5947 | Details Get a Quote |
| RBP1 Knockout HCT 116 Cell Line | EDJ-KQ28979 | Human | 5947 | Details Get a Quote |
| RBP1 Knockout HeLa Cell Line | EDJ-KQ28980 | Human | 5947 | Details Get a Quote |
| ALDH1A2 Knockout HeLa Cell Line | EDJ-KQ30393 | Human | 8854 | Details Get a Quote |
| LRAT Knockout HEK293 Cell Line | EDJ-KQ50854 | Human | 9227 | Details Get a Quote |
| RBP2 Knockout HeLa Cell Line | EDJ-KQ54300 | Human | 5948 | Details Get a Quote |
| RLBP1 Knockout HeLa Cell Line | EDJ-KQ54327 | Human | 6017 | Details Get a Quote |
| RPE65 Knockout HeLa Cell Line | EDJ-KQ54339 | Human | 6121 | Details Get a Quote |
| LRAT Knockout HeLa Cell Line | EDJ-KQ55105 | Human | 9227 | Details Get a Quote |
| RBP2 Knockout A-549 Cell Line | EDJ-KQ62795 | Human | 5948 | Details Get a Quote |
Displaying Records 1 To 15 Of 24 Records
Frequently Asked Questions About vitamin A metabolic process
What is GO:0006776 vitamin A metabolic process?
GO:0006776 is a Gene Ontology biological process term defined as the chemical reactions and pathways involving retinol, retinal, and retinoic acid, all derivatives of beta-carotene.
What genes are involved in vitamin A metabolic process?
Key genes include BCO1, BCO2, LRAT, RPE65, ALDH1A1/2/3, CYP26A1/B1/C1, CRBP1/2, RBP4, STRA6, and retinoic acid receptors RARA/B/G and RXRA.
Why is vitamin A metabolism important for health?
It is essential for vision, immune function, epithelial differentiation, and development, and its disruption is linked to diseases like NAFLD and vitamin A deficiency.
How is vitamin A metabolic process regulated?
It is regulated by dietary intake, enzymatic synthesis and degradation of retinoic acid, and transcriptional feedback involving nuclear receptors.
What diseases are associated with disturbed vitamin A metabolism?
Non-alcoholic fatty liver disease, vitamin A deficiency, developmental defects, and skin disorders have been associated with altered vitamin A metabolism.
What methods are used to study vitamin A metabolic process?
CRISPR screening, RNA-seq, metabolomics, proteomics, reporter assays, and imaging are commonly used to study this pathway.
Can CRISPR be used to model vitamin A metabolism disorders?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise dissection of gene function in vitamin A metabolism.
What is the role of retinoic acid in gene regulation?
Retinoic acid binds to nuclear receptors (RARs/RXRs) to regulate transcription of target genes involved in development and metabolism.
How does vitamin A metabolism affect brown fat?
The transcriptional role of vitamin A and the retinoid axis influences brown adipose tissue function and energy expenditure.
What is the connection between vitamin A metabolism and NAFLD?
Disturbed vitamin A metabolism has been observed in NAFLD, suggesting a role in disease progression.
Conclusion
GO:0006776 vitamin A metabolic process is a fundamental biological pathway that governs the production, interconversion, and action of retinol, retinal, and retinoic acid. Its importance spans vision, development, immunity, and metabolism, with dysregulation implicated in diseases such as NAFLD and vitamin A deficiency. Advances in CRISPR-based models and multi-omics technologies are accelerating our understanding of this pathway and its therapeutic potential. Continued research into GO:0006776 will illuminate new strategies for nutritional and pharmacological interventions.
References
- 1. Roels OA. 1970. Vitamin A physiology.. JAMA 214(6):1097-102 PMID: 4920145
- 2. Biesalski HK et al.. 2008. Nutritargeting.. Adv Food Nutr Res 54:179-217 PMID: 18291307
- 3. Saeed A et al.. 2017. Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD).. Nutrients 10(1) PMID: 29286303
- 4. AMES SR. 1958. Fat-soluble vitamins.. Annu Rev Biochem 27(3):371-402 PMID: 13571938
- 5. Herz CT et al.. 2020. The Transcriptional Role of Vitamin A and the Retinoid Axis in Brown Fat Function.. Front Endocrinol (Lausanne) 11:608 PMID: 33071960
- 6. Wolf G. 1984. Multiple functions of vitamin A.. Physiol Rev 64(3):873-937 PMID: 6377341
- 7. McLaren DS et al.. 2012. Vitamin A in health.. World Rev Nutr Diet 103:33-51 PMID: 23008036
- 8. Logan WS. 1972. Vitamin A and keratinization.. Arch Dermatol 105(5):748-53 PMID: 4554725
